Lung
-
In the largest and longest follow-up study to date investigating the lingering effects of COVID-19, researchers have found more than two-thirds of hospitalized patients report at least one ongoing symptom six months after contracting the disease.
-
A new study is the first to investigate the relationship between chronic obstructive pulmonary disease and the gut microbiome. The preliminary investigation confirms patients suffering from COPD present with changes to microbial populations in the gut.
-
Cancer spreads easily, and a common location for secondary tumors to appear is the lungs. Now, scientists at Harvard’s Wyss Institute have developed a way to treat metastatic tumors in the lungs, by attaching immune-baiting drugs to red blood cells.
-
A proof-of-concept study proposes a novel, cheap and surprisingly simple way to rapidly reduce blood alcohol levels. The research suggests a low-tech device aiding safe hyperventilation can more than triple the rate of alcohol elimination from the body.
-
An international team of scientists has identified a protein in the lungs that offers a new target for asthma treatments, along with another common condition affected by inflammation in the lungs, in chronic obstructive pulmonary disease (COPD).
-
Treatments for blood clots in the body naturally come with a risk of excessive bleeding from an injury. But a new synthetic blood thinner bypasses this side effect, fighting thrombosis while still allowing blood to clot normally in a wound.
-
A new type of nanoparticle developed at MIT deposits volatile molecules onto proteins linked to various diseases, to act as synthetic biomarker and reveal signs of pneumonia and other lung conditions in exhaled breath.
-
A tiny new sensor that can be worn in items of clothing could offer a new way to tap into the subtle vibrations produced by a wearer's heart and lungs, and even alert the user when it might be time to head for a checkup.
-
Asthma and other allergic reactions are increasingly common today, and while manageable there’s currently no cure. Now, researchers at Yale University have found a new potential pathway for treatment, targeting cellular "gatekeepers" called microRNA.
-
After months of concern, the CDC has revealed it's confident in claiming the “vast majority” of recent lung injury cases related to e-cigarette use can be linked to illicit THC vape liquids containing vitamin E acetate.
-
Much like the gut, skin and mouth, our respiratory system is home to its own unique microbial population. Intriguing new research has now found a link between specific bacterial populations in the upper airways and the severity of asthma symptoms.
-
While cautioning that further research is needed to establish a causal link, the CDC has identified vitamin E acetate as the prime suspect responsible for e-cigarette and vaping product associated lung injury (EVALI).